J3031 HCPCS Level II code: Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is…
J3031 is the HCPCS code for “Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J3031Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)
Short description: Inj., fremanezumab-vfrm 1 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J3031 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Oct 1, 2019
Where J3031 sits
- 1J codesDrugs administered other than orally
- 2Active code J3031Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J3031 mean?
J3031 is the HCPCS code for “Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J3031?
CMS lists J3031’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J3031
All J codesJ2995Injection, streptokinase, per 250,000 iuJ2997Injection, alteplase recombinant, 1 mgJ2998Injection, plasminogen, human-tvmh, 1 mgJ3000Injection, streptomycin, up to 1 gmJ3010Injection, fentanyl citrate, 0.1 mgJ3030Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self…J3032Injection, eptinezumab-jjmr, 1 mgJ3055Injection, talquetamab-tgvs, 0.25 mgJ3060Injection, taliglucerase alfa, 10 unitsJ3070Injection, pentazocine, 30 mgJ3090Injection, tedizolid phosphate, 1 mgJ3095Injection, telavancin, 10 mg